Clomifene
- Generic Name
- Clomifene
- Brand Names
- Clomid
- Drug Type
- Small Molecule
- Chemical Formula
- C26H28ClNO
- CAS Number
- 911-45-5
- Unique Ingredient Identifier
- 1HRS458QU2
- Background
A triphenyl ethylene stilbene derivative which is an estrogen agonist or antagonist depending on the target tissue.
- Indication
Used mainly in female infertility due to anovulation (e.g. due to polycystic ovary syndrome) to induce ovulation.
- Associated Conditions
- Ovulatory Dysfunction
- Associated Therapies
- -
Treatment of Anovulatory Infertility in PCOS Patients
- Conditions
- First Posted Date
- 2007-05-10
- Last Posted Date
- 2007-05-10
- Lead Sponsor
- University Magna Graecia
- Target Recruit Count
- 80
- Registration Number
- NCT00471523
- Locations
- 🇮🇹
"Pugliese Hospital", Catanzaro, CZ, Italy
Tamoxifen Compared With Clomiphene Citrate for Women Who Had Thin Endometrium Women Under Clomiphene in a Previous Cycle
- Conditions
- First Posted Date
- 2007-03-20
- Last Posted Date
- 2007-09-20
- Lead Sponsor
- Shaare Zedek Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT00449514
- Locations
- 🇮🇱
Shaare-Zedek Medical Center, Jerusalem, Israel
Induction of Ovulation With Raloxifene or Clomiphene Citrate in Polycystic Ovarian Syndrome
- Conditions
- Interventions
- First Posted Date
- 2007-01-29
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Hospital de Clinicas de Porto Alegre
- Target Recruit Count
- 82
- Registration Number
- NCT00427700
- Locations
- 🇧🇷
Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil
The Effect of Metformin Added to Clomiphene Citrate on Pregnancy Rates in Hyperandrogenic, Chronic Oligoovulatory or Anovulatory Women
- Conditions
- First Posted Date
- 2006-12-19
- Last Posted Date
- 2006-12-19
- Lead Sponsor
- 59th Medical Wing
- Target Recruit Count
- 56
- Registration Number
- NCT00413179
- Locations
- 🇺🇸
Wiford Hall Medical Center, Lackland AFB, Texas, United States
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH
- Conditions
- Interventions
- First Posted Date
- 2006-02-27
- Last Posted Date
- 2011-05-19
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 132
- Registration Number
- NCT00296465
- Locations
- 🇺🇸
Southern Fertility Center and Clinical Research, Metairie, Louisiana, United States
Treatment of Infertility in Women With Polycystic Ovary Syndrome
- Conditions
- First Posted Date
- 2003-09-11
- Last Posted Date
- 2007-10-01
- Target Recruit Count
- 678
- Registration Number
- NCT00068861
- Locations
- 🇺🇸
University of Colorado, Aurora, Colorado, United States
🇺🇸University of Medicine and Dentistry New Jersey, Newark, New Jersey, United States
🇺🇸University of California at San Diego, La Jolla, California, United States
Randomized Study of the Effect of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Obese Women With Polycystic Ovary Syndrome
- Conditions
- First Posted Date
- 2000-05-03
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- National Center for Research Resources (NCRR)
- Target Recruit Count
- 88
- Registration Number
- NCT00005654
Randomized Study of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Women With Polycystic Ovary Syndrome
- Conditions
- First Posted Date
- 2000-04-07
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- National Center for Research Resources (NCRR)
- Target Recruit Count
- 99
- Registration Number
- NCT00005104
- Locations
- 🇺🇸
Louisiana State University School of Medicine, Shreveport, Louisiana, United States
🇺🇸Washington University - St. Louis, St. Louis, Missouri, United States
🇮🇹University Alma Mater, Bologna, Italy
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.